NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
13.02
+0.03 (0.23%)
Oct 27, 2026, 4:00 PM EDT - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $446.9 million as of October 27, 2026. It is the 15,295th most valuable company in the world and the 2,814th biggest in the United States. Its market cap has increased by 28.90% in one year.
Market Cap
446.90M
Enterprise Value
465.13M
1-Year Change
28.90%
Global Rank
Country Rank
#2,814 United States
Category
ChartMarket Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $446.90M, an increase of 13.63%. That is a compound annual growth rate of 2.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 446.90M | -13.10% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tactile Systems Technology | 531.42M |
| Delcath Systems | 511.81M |
| 908 Devices | 510.88M |
| SS Innovations International | 500.96M |
| Sight Sciences | 497.44M |
| AVITA Medical | 497.30M |
| Cerus | 483.66M |
| BrainsWay | 451.36M |